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Abstract  
Background:
            The hemodynamic advantages of maintaining AV synchrony through AV synchronous 
pacing are widely known as compared to single chamber pacing. DDD pacemaker implantation 
entails   higher   cost   and   is   technically   more   challenging   than   the   VDD   pacemaker.
Methods:
            Seventy one patients underwent VDD lead (Biotronik GmbH, St. Jude Medical and 
Medtronic Inc.) implantation at KEM hospital, Mumbai during a period of 3 years through 
subclavian, axillary and cephalic routes for degenerative, post-surgical or congenital high grade 
atrioventricular or complete heart block. They were followed up regularly for ventricular 
threshold and P wave amplitude of the floating atrial dipole.                                     
Results:
            Follow up data of almost 95% of patients is available for a period of 15.8 ± 6.7 months. 
P wave amplitude at implant was 2.1 ± 0.7mV and at follow up 1.1 ± 0.6mV with mean 
ventricular threshold of <0.5V at implant and <1V at follow-up.                                           
Conclusion:
               Implantation of a single lead VDD pacemaker is possible in all patients with 
symptomatic AV block and intact sinus node function without any technical complications. P 
wave sensing is reliable and consistent with floating atrial lead at an average follow up of 15.8 
months, providing an excellent alternative to DDD pacemaker implantation.                             
Key Words: VDD Lead; P wave Amplitude; Atrial Sensitivity; Atrioventricular synchronous 
Pacing
Introduction
               The   modalities   of   synchronous   atrioventricular   (AV)   pacing   in   patients   with 
symptomatic AV Block include VDD mode of pacing, besides the DDD mode which is accepted 
as a gold standard modality. Technical difficulties in placing atrial lead, higher cost of the 
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procedure due to need for second (atrial) lead are the limitations of DDD mode of pacing. Here 
we propose to evaluate the stability of single lead VDD pacemaker in terms of atrial signal 
detection   via   floating   atrial   electrode.                                                                  
Methods:
Patients:
            Seventy one patients with high degree AV block underwent implantation of a VDD 
pacemaker from December 2002 through November 2005 at KEM Hospital, Mumbai. The 
patients who underwent VDD pacemaker implantation were evaluated by 24 hours ECG 
monitoring / chronotropic sinus node response to stress for sinus node function. Patients with 
sinus node dysfunction and / or atrial arrhythmias were not eligible for VDD pacemaker 
implantation.
               The indications for VDD pacing   were degenerative   high grade AV block in 66, 
complete heart block (CHB) following aortic valve replacement in 3, intracardiac repair for 
partial AV canal defect in 1 and congenital CHB in 1.                                                             
Pacemaker   system:                                                        
            The Solox quadripolar single VDD Pacing Lead electrode (Biotronik GmbH,Germany), 
model 1368 VDD Pacing Lead (St. Jude Medical,USA) and  model 5038 CapSure®VDD Pacing 
Lead (Medtronic Inc.,USA) were implanted in 48,13 and 10 patients respectively. Leads with 
separation distance of 13cm and 11cm between ventricular tip and atrial dipole were used in 68 
and   3   patients   respectively.                                                        
Implantation   technique:                                                  
               The implantation of single VDD lead (6.3 Fr) was performed by subclavian vein 
puncture in 52 patients, by axillary vein puncture in 11 patients and by cephalic vein cut down in 
8   patients.   Axillary   vein   puncture   was   guided   by   ipsilateral   contrast   venogram.
After the placement of the electrode tip into the right ventricle, the ventricular pacing threshold, 
the amplitude of R wave (wherever feasible), the lead impedance and the slew rate were 
determined. P wave amplitude was measured during normal and deep breaths and during cough 
after the atrial dipole was positioned in visually optimal position. By adjusting the intravascular 
length of the lead, the best atrial sensing was determined. The lead position and parameters were 
rechecked after coughing and diaphragmatic pacing was ruled out before fixing the leads. 
Eventually the lead was attached to the pulse generator and the pulse generator was implanted in 
the prepectoral pocket. Upper and lower tracking rate limits were determined and atrial 
sensitivity and paced AV delay were programmed to maximize AV synchronous pacing.
Follow   up:                                                                                        
            Patients were discharged 2 days post implantation after confirming the lead position on 
penetrated  chest  roentgenograms   and  confirming  the  lead  parameters  including  P  wave 
amplitude. If required, the reprogramming was done to adjust atrial sensitivity and to optimize 
AV synchronous pacing. They were reexamined for the status of the wound at the site of 
pacemaker implantation after 10 ± 2 days. The pacemaker was interrogated after 2 to 3 months 
of follow up and subsequently at every 6 monthly follow-up visits.                                           
Statistics:
            Values obtained were analyzed using SPSS software for Windows to obtain mean and 
standard   deviation  (SD).   The  expressed  values   in  the  text   /  table  are   mean  ±  1  SD.
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Results (Table 1 and 2):
Table 1:  Study Profile
 
Table 2: VDD Lead Parameters
 
            Out of 71 patients who underwent VDD pacemaker implantation 1 patient expired of 
acute coronary event and 3 others haven't followed up subsequently hitherto. The duration of 
follow up for the rest 67 subjects has been 15.8 ± 6.7 months. Two patients experienced loss of 
atrial sensing on day 1 and at 9 months follow up respectively. The pacing mode was switched 
over from VDD to VVI in both. Two months later, the first patient had good P wave amplitude 
and the mode was switched over to VDD again. Another 6 months later, the P wave height was 
1.9 mV (3 mV at implant) with the ventricular threshold of 0.9 V (0.5 V at implant), thereby 
obviating   repositioning   of   the   lead.                                                      
            Another patient who underwent VDD pacemaker implantation for CHB expired 6 days 
after implantation of refractory heart failure following an acute coronary event sustained on day 
2 post procedure. The pacing parameters throughout the turbulent postoperative period were 
satisfactory   with   P   wave   amplitude   of   3   mV   and   ventricular   threshold   of   0.4   V.  
Discusssion:
            The hemodynamic advantages of maintaining AV synchrony through AV synchronous 
pacing are widely known as compared to single chamber pacing. DDD pacemaker implantation 
is technically more challenging in terms of the need to insert a second lead into the atrium for 
sensing and pacing the atria. This also increases the cost of the procedure and the total 
fluoroscopy time of the procedure. A further disadvantage is high complication rate with atrial 
(2.9 % in Parromet and Bernstein series,1   11 % Brownlee series2 ). The complications include 
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lead dislocation, loss of atrial sensing, lead fracture, etc.  Diminution of atrial sensing threshold 
is seen with walking, running and exercise in standing posture (Froehlig et al series,3,4  Zitzmann 
et al series5 ).                                                                            
            Single lead VDD pacing offers an opportunity for AV synchronous pacing with the 
simplicity   of   VVI   implantation   procedure   and   without   complexity   of   atrial   electrode.
            Out of 67 cases that followed up with us, just one case has been found to have loss of 
atrial sensing at follow up visit. In another case there was loss of atrial sensing on day 2 that 
reverted spontaneously at subsequent follow up visit without entailing repositioning of the lead. 
Thus, only one patient was found to have loss of atrial sensing at 9 months of follow up. The 
ultimate goal of VDD pacing is a chronically stable P wave sensing. Studies have shown atrial 
sensing performance of > 94 % in the majority of them so far.6-9 Though it is not predictable the 
loss of AV synchrony can be minimized by achieving a large and a stable intraoperative P wave 
amplitude, by positioning the atrial dipole in high right atrium and keeping the programmable 
atrial sensitivity to as low a value as possible with the available VDD lead (0.1mV in our 
study).10 
              None of our patients has developed atrial arrhythmias on follow up. In one of the 
multicenter study 2.1 % of the patients treated with VDD developed atrial fibrillation (AF).11  
The incidences in two other studies are 7 % and 6.4 % respectively.8,12 This is accounted by a 
large number of patients with organic heart disease and patients with Aortic / Mitral valve 
replacement who needed VDD pacemaker in these   studies. Four patients with organic heart 
disease have undergone VDD pacemaker implantation but haven't had atrial fibrillation so far. 
Although rare, sick sinus syndrome may develop in patients with AV block (binodal disease). 
As   the   atrium   can't   be   paced,   this   may   be   the   major   drawback   of   VDD   mode.8
            However studies are tried to stimulate atria using overlapping biphasic impulse (OLBI) 
stimulation waveform delivered via an atrial floating electrode but this is limited by high pacing 
threshold due to unstable atrial floating lead position and also by phrenic nerve stimulation 
which   is   often   observed   with   high   right   atrial   position   of   the   VDD   lead.13
               As of now, a careful patient selection as like excluding patients with sinus node 
dysfunction   and   intermittent   /   persistent   atrial   fibrillation/flutter   is   required.
Study   Limitations:                                                                                
            All the patients who were considered for VDD permanent pacemaker in this study were 
evaluated for the sinus node function either by 24 hour Holter or Exercise ECG before 
implantation.  They have not been evaluated post implantation through Holter monitoring which 
helps to assess the variation in the P wave amplitude during routine work, postural changes and 
moments of unusual physical and non-physical stress. It is in these situations that the best of the 
utilities of VDD pacing is assessed viz.  Preservation of AV synchrony and thereby retention of 
the  most  physiological  rate  response  to  stress  even  with  a  single  pacing  lead  system.
            Because the working amplitude of P wave varies with posture and exercise it can be 
reproducibly assessed in a controlled manner through Tread Mill Test (TMT). The episodic 
occurrence of VVI pacing during the test suggests loss of atrial sensing during that particular 
phase of the test. In this study, we have not resorted to TMT on follow up which is advisable for 
a comprehensive assessment of the stability of atrial dipole through actual period of day to day 
work.  
Conclusion:
            It has been shown in the present study that the implantation of a new VDD single lead 
pacemaker was possible in all patients with symptomatic AV block and intact sinus node 
function without any technical complication of the pacemaker system. P wave sensing was 
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reliable and consistent with floating atrial lead at an average follow up of 15.8 months as 
assessed from the retrieval of stored histograms. Post implantation, 24 hour Holter and TMT 
give comprehensive assessment of the stability of the floating atrial electrodes. The VDD pacing 
offers an excellent alternative to conventional DDD stimulation.                                               
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